Therefore, the use of amisulpride from puberty to the age of 18 years is not recommended; in children up to puberty amisulpride is contraindicated, as its safety has not yet been established (see section 4.3).Amisulpride is eliminated by the renal route.
Unless your doctor tells you otherwise, amisulpride should not be stopped suddenly as this may cause withdrawal effects such as muscle stiffness or unusual body movements.Taking amisulpride may affect the results of some blood tests. This medication is an atypical antipsychotic agent, prescribed for schizophrenia. When suggestions are available use up and down arrows to review and ENTER to select.
Amisulpride 200 mg tablets are white, round with 11 mm diameter and flat. Common: somnolence, acute dystonia (spasm torticollis, oculogyric crisis, trismus) may appear. The release of prolactin may result in problems such as galactorrhoea and amenorrhoea. Do not stop taking your medicine just because you feel better as your illness may get worse or come back. Keep your regular appointments with your doctor. Description Amisulpride 200 MG Tablet is an atypical anti-psychotic medicine that is used to treat symptoms like hallucinations, delusions, thought disturbances, lack of interest, apathy etc. This is reversible without discontinuation of amisulpride upon treatment with an antiparkinsonian agent. Changes observed in rats and dogs at doses below the maximum tolerated dose are either pharmacological effects or are devoid of major toxicological significance under these conditions. In individual cases, the daily dose may be increased up to 1200 mg/d. Amisulpride 400mg Film Coated Tabs. I am taking Amisulpride 200 mg 1-0-1, along with Quetiapine 100 mg 1-1-1 and Respiredone 2 mg 1-0-2 for my Schizophrenia. An overall review of the completed safety studies indicates that amisulpride is devoid of any general, organ-specific, teratogenic, mutagenic or carcinogenic risk.
Amisulpride should be used with caution in patients with stroke risk factors.Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.